Integral Health Asset Management as of June 30, 2024
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 69 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 9.9 | $104M | 1.6M | 67.00 | |
| Tenet Healthcare Corp Com New (THC) | 6.3 | $67M | 500k | 133.03 | |
| Cytokinetics Com New (CYTK) | 5.1 | $54M | 1.0M | 54.18 | |
| Boston Scientific Corporation (BSX) | 4.8 | $50M | 650k | 77.01 | |
| Anthem (ELV) | 4.1 | $43M | 80k | 541.86 | |
| Blueprint Medicines (BPMC) | 3.5 | $37M | 340k | 107.78 | |
| Ionis Pharmaceuticals (IONS) | 3.4 | $36M | 750k | 47.66 | |
| Novartis Sponsored Adr (NVS) | 3.0 | $32M | 300k | 106.46 | |
| Longboard Pharmaceuticals In | 2.8 | $30M | 1.1M | 27.03 | |
| Merck & Co (MRK) | 2.8 | $29M | 235k | 123.80 | |
| Humana (HUM) | 2.7 | $28M | 75k | 373.65 | |
| Tarsus Pharmaceuticals (TARS) | 2.6 | $27M | 990k | 27.18 | |
| Viking Therapeutics (VKTX) | 2.5 | $27M | 500k | 53.01 | |
| Encompass Health Corp (EHC) | 2.4 | $26M | 300k | 85.79 | |
| Universal Hlth Svcs CL B (UHS) | 2.3 | $24M | 130k | 184.93 | |
| Inari Medical Ord | 1.8 | $19M | 400k | 48.15 | |
| Vera Therapeutics Cl A (VERA) | 1.7 | $18M | 500k | 36.18 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $18M | 400k | 44.79 | |
| Becton, Dickinson and (BDX) | 1.7 | $18M | 75k | 233.71 | |
| Cigna Corp (CI) | 1.6 | $17M | 50k | 330.57 | |
| Krystal Biotech (KRYS) | 1.5 | $16M | 85k | 183.64 | |
| Arcellx Common Stock (ACLX) | 1.4 | $15M | 275k | 55.19 | |
| Icon SHS (ICLR) | 1.3 | $14M | 45k | 313.47 | |
| Edwards Lifesciences (EW) | 1.3 | $14M | 150k | 92.37 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $14M | 25k | 553.00 | |
| Quest Diagnostics Incorporated (DGX) | 1.3 | $14M | 100k | 136.88 | |
| Revolution Medicines (RVMD) | 1.2 | $13M | 325k | 38.81 | |
| Amgen (AMGN) | 1.2 | $13M | 40k | 312.45 | |
| McKesson Corporation (MCK) | 1.1 | $12M | 20k | 584.04 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $11M | 950k | 11.70 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $9.9M | 145k | 68.49 | |
| Sanofi Sponsored Adr (SNY) | 0.9 | $9.7M | 200k | 48.52 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.9 | $9.7M | 220k | 43.97 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $9.6M | 70k | 137.67 | |
| Teleflex Incorporated (TFX) | 0.9 | $9.5M | 45k | 210.33 | |
| Eli Lilly & Co. (LLY) | 0.9 | $9.1M | 10k | 905.38 | |
| Globus Med Cl A (GMED) | 0.8 | $8.6M | 125k | 68.49 | |
| Bruker Corporation (BRKR) | 0.8 | $8.3M | 130k | 63.81 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.8 | $8.1M | 150k | 54.01 | |
| Oscar Health Cl A (OSCR) | 0.8 | $7.9M | 500k | 15.82 | |
| Repligen Corporation (RGEN) | 0.7 | $7.6M | 60k | 126.06 | |
| Denali Therapeutics (DNLI) | 0.7 | $7.5M | 325k | 23.22 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $7.2M | 2.3M | 3.10 | |
| Sana Biotechnology (SANA) | 0.6 | $6.6M | 1.2M | 5.46 | |
| Elanco Animal Health (ELAN) | 0.6 | $6.5M | 450k | 14.43 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $6.4M | 1.8M | 3.60 | |
| Merus N V (MRUS) | 0.6 | $5.9M | 100k | 59.17 | |
| Insulet Corporation (PODD) | 0.5 | $5.0M | 25k | 201.80 | |
| Quidel Corp (QDEL) | 0.5 | $5.0M | 150k | 33.22 | |
| Relay Therapeutics (RLAY) | 0.5 | $4.9M | 750k | 6.52 | |
| Surgery Partners (SGRY) | 0.5 | $4.8M | 200k | 23.79 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.4 | $4.5M | 100k | 45.25 | |
| Intuitive Surgical Com New (ISRG) | 0.4 | $4.4M | 10k | 444.85 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $4.3M | 275k | 15.49 | |
| Roivant Sciences SHS (ROIV) | 0.4 | $4.2M | 400k | 10.57 | |
| Keros Therapeutics (KROS) | 0.4 | $3.9M | 85k | 45.70 | |
| Hologic (HOLX) | 0.4 | $3.7M | 50k | 74.25 | |
| 89bio (ETNB) | 0.3 | $3.6M | 450k | 8.01 | |
| Dyne Therapeutics (DYN) | 0.3 | $3.5M | 100k | 35.29 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $3.3M | 400k | 8.33 | |
| Cabaletta Bio (CABA) | 0.3 | $3.2M | 425k | 7.48 | |
| Editas Medicine (EDIT) | 0.3 | $3.2M | 675k | 4.67 | |
| Apogee Therapeutics (APGE) | 0.3 | $3.1M | 80k | 39.35 | |
| Nurix Therapeutics (NRIX) | 0.3 | $3.1M | 150k | 20.87 | |
| Fate Therapeutics (FATE) | 0.3 | $2.8M | 850k | 3.28 | |
| Neurogene (NGNE) | 0.2 | $2.5M | 70k | 36.39 | |
| Spyre Therapeutics Com New (SYRE) | 0.2 | $2.4M | 100k | 23.51 | |
| Kura Oncology (KURA) | 0.2 | $2.1M | 100k | 20.59 | |
| Revance Therapeutics | 0.1 | $1.3M | 500k | 2.57 |